Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02982941
Title Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Indications

rhabdomyosarcoma

neuroblastoma

Advanced Solid Tumor

Ewing sarcoma

nephroblastoma

osteosarcoma

Therapies

MGA271

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.